Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Use of the combination of PHY906 and a tyrosine kinase inhibitor as a cancer treatment regimen

Use of the combination of PHY906 and a tyrosine kinase inhibitor as a cancer treatment regimen

US Patent 8871279 · Granted Oct 28, 2014

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Herbal composition PHY906 and its use in chemotherapy2025
Herbal composition PHY906 and its use in chemotherapy2025
Herbal composition PHY906 and its use in chemotherapy2025
Herbal composition PHY906 and its use in chemotherapy2024
Herbal composition PHY906 and its use in chemotherapy2024
Herbal composition PHY906 and its use in chemotherapy2024
Mechanism based quality control for botanical medicine2024
Inhibition of androgen receptor by extracts of medicinal herbs and compositions 2023
Inhibition of androgen receptor by extracts of medicinal herbs and compositions 2023
Herbal composition PHY906 and its use in chemotherapy2023
Herbal composition PHY906 and its use in chemotherapy2023
Herbal composition PHY906 and its use in chemotherapy2023